Search Medical Condition
Please enter condition
Please choose location from dropdown

Bruderholz, Switzerland Clinical Trials

A listing of Bruderholz, Switzerland clinical trials actively recruiting patients volunteers.

RESULTS

Found (216) clinical trials

Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup

This is a randomized controlled trial with the seleXys PC cup and RM Pressfit vitamys cup in combination with the optimys short stem. Wear rate and migration is assessed with roentgen stereophotogrammetric analysis (RSA) measurements.

Phase N/A

0.0 miles

Learn More »

Global Non-interventional Heart Failure Disease Registry

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for ...

Phase N/A

0.32 miles

Learn More »

Chronic Subdural Hematoma and Aspirin

Chronic subdural hematoma (cSDH) is one of the most common neurosurgical conditions. Its significantly higher prevalence among patients older than 65 (69%) versus younger (31%) explains why 41% of the patients are taking blood thinners. Antiplatelet therapy in patients with chronic subdural hematoma (cSDH) presents significant neurosurgical challenges. Studies investigating ...

Phase N/A

0.78 miles

Learn More »

Microarchitecture Bone Strength and Fracture Risk in Type 2 Diabetes

Cross-sectional evaluation of clinical, biochemical and microstructural measures of bone in patients with type 2 diabetes and age-matched healthy controls. Longitudinal assessment of clinical, biochemical and microstructural measures of bone in study participants without prevalent fragility fractures.

Phase N/A

0.84 miles

Learn More »

SPECT-CT for Assessment of Total Knee Arthroplasty in Navigated and Non-navigated Total Knee Arthroplasty

With SPECT/CT we want to controll the clinical outcome of patients who underwent a navigated or a non-navigated TKR.

Phase N/A

0.84 miles

Learn More »

TFNA Weight Bearing

Prospective data will be collected from 30 patients presenting a per- or inter-trochanteric fracture of the femur treated with the TFNA. Post-operatively patients will be asked to wear a sensor insole in their shoes for up to 3 months after surgical treatment. The sensor insole will be used in both ...

Phase N/A

0.84 miles

Learn More »

Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma

Despite the encouraging results of recent trials, only a minority of patients shows significant response to single agent immunotherapy with nivolumab (Overall response rate (ORR) around 20%). Therefore, further investigations are urgently needed to improve the prognosis of patients with mRCC. Recent analyses of phase I trials in mRCC and ...

Phase

0.84 miles

Learn More »

Taper Or Abrupt Steroid Stop: TOASSTtrial

In total, 573 patients will be enrolled. Patients will be randomly assigned in a 1:1 ratio to either prednisone in decreasing doses over 4 weeks or placebo. Patients, treating physicians, and study personnel will be blinded to treatment allocation to either prednisone or matching placebo. At inclusion, we will perform ...

Phase

0.84 miles

Learn More »

Comparison of the Femoral Prothesis-rotation in Conventional X-ray in Axial CT Slices and 3D-reconstructed CT

Femoral component rotation in total knee arthroplasty (TKA) has been considered an important factor for outcome. However, measurement of femoral component rotation is difficult to perform. Femoral TKA component rotation can be assessed on special radiographs (Kanekasu technique), axial CT slices and 3D reconstructed CT images. It was the hypothesis ...

Phase N/A

0.84 miles

Learn More »

Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)

Despite multimodal therapy, the cure rate of patients with stage IIIA NSCLC is poor and therapy outcome failed to improve during the past years. The addition of immunotherapy with the anti-PD-L1 antibody MEDI4736 as a novel treatment modality has the potential to improve the outcome without adding substantial toxicity to ...

Phase

0.84 miles

Learn More »